Idex stock remains Mizuho’s top pick on AI chip growth outlook

Mizuho named Idex its preferred semiconductor-growth exposure after TSMC’s stronger-than-expected Q3 2026 results and raised fiscal 2026 revenue-growth forecast of about 44% in U.S. dollar terms. TSMC maintained its $60 billion–$64 billion 2026 capex outlook and expects 2026–2028 spending to significantly exceed the prior three years, supporting demand for semiconductor equipment and fab infrastructure. The article also notes Parker-Hannifin completed its $9.25 billion Filtration Group acquisition and received mixed analyst ratings.

Analysis

The investable signal is not simply “AI capex is strong”; it is that fab construction and capacity additions may broaden demand beyond accelerator and wafer-fab names into process-control, fluid-handling, precision instrumentation, electrical and cooling suppliers. That creates a lagged, less obvious second leg: infrastructure orders can persist even if near-term chip sentiment or semiconductor multiples wobble. IDEX and AMETEK offer exposure to that supplier layer; neither should be valued as a direct proxy for TSMC’s growth, since conversion depends on project timing, product content and customer qualification.

The main near-term risk is multiple compression: hot producer-price data and renewed rate volatility can pressure growth-sensitive semiconductor equities before equipment and infrastructure orders show up in reported results. Over 1–3 months, watch TSMC’s capex execution and supplier order commentary; over 6–18 months, utilization, fab commissioning delays and the durability of AI demand determine whether today’s build-out supports returns or produces excess capacity. TSMC’s higher investment also raises the eventual depreciation and utilization hurdle; capex growth alone is not proof of attractive returns.

PH has an additional, separate driver: integration and balance-sheet execution after its acquisition. The reported valuation concern is a caution, not an independently established valuation conclusion. The consensus may underappreciate the duration of fab-infrastructure demand, but may overstate how quickly that demand becomes earnings. Confirmation should come from order growth and guidance, not broker enthusiasm.

Key Decisions for Investors

• Prefer a staged long in IEX and AME on broad semiconductor-sector weakness rather than chasing TSM headlines; scale only if subsequent company commentary confirms orders tied to fab and infrastructure projects. Thesis horizon: 6–18 months; falsify if order trends or guidance weaken despite continued TSM capex.
• Consider a relative-value long IEX / underweight PH only after checking current valuation, beta and earnings sensitivity. This expresses cleaner exposure to the cited equipment/infrastructure thesis against PH’s acquisition-integration and PMI risks; do not assume the pair is valuation-neutral without those checks.
• Keep TSM as a capex-cycle monitor, not a pure supplier long: track project timing, utilization and returns on investment alongside spending. A material capex reduction, fab delays, or evidence that AI demand is not translating into sustained capacity use would invalidate the broader supplier thesis.
• No immediate options trade: the article supplies no price levels, implied volatility, or evidence of a near-term catalyst strong enough to justify paying premium. Reassess after TSM’s next guidance update and supplier order disclosures.